NCT06383468 A Phase III Study to Evaluate the Efficacy and Safety of AK120 in Patients With Moderate to Severe Atopic Dermatitis Status RECRUITING Phase PHASE3
NCT06378697 A Phase III Study to Evaluate the Efficacy and Safety of AK111 in Subjects With Active Ankylosing Spondylitis Status COMPLETED Phase PHASE3
NCT06371157 A Study of AK104+Lenvatinib in Combination With Transarterial Chemoembolization (TACE) Versus TACE in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma Status RECRUITING Phase PHASE3
NCT06341335 A Study of AK104/Placebo Plus AK109/Placebo And Paclitaxel in Gastric or Gastroesophageal Junction Adenocarcinoma Status RECRUITING Phase PHASE3
NCT06292689 A Phase II, Single-arm, Multicenter, Prospective Study of Cardunolizumab in Recurrent or Metastatic Vulvar and Vaginal Cancer Status RECRUITING Phase PHASE2
NCT06281704 A Study of AK101 in Subjects With Moderately to Severely Active Ulcerative Colitis Status COMPLETED Phase PHASE1
NCT06196203 A Study of AK117 in Combination With Azacitidine in Patients With Myelodysplastic Syndromes Status RECRUITING Phase PHASE2
NCT06166472 A Study to Evaluate the Safety, Tolerance, Pharmacokinetics, and Preliminary Antineoplastic Activity of AK132 in Advanced Malignant Solid Tumor Status NOT_YET_RECRUITING Phase PHASE1
NCT06092762 A Study to Evaluate the Safety and Efficacy of AK120 in Subjects With Moderate to Severe Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT06066125 A Study to Evaluate the Efficacy and Safety of AK111 in Subjects With Moderate to Severe Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT06061471 To Evaluate the Efficacy and Safety of AK111 Injection in the Treatment of Moderate to Severe Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT06035354 A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of AK120 in Subjects With Atopic Dermatitis Status COMPLETED Phase PHASE1/PHASE2
NCT05990127 A Study of AK104/Tislelizumab With Chemotherapy as First-line Treatment in PD-L1 TPS < 1% Non-small Cell Lung Cancer Status NOT_YET_RECRUITING Phase PHASE3
NCT05980689 Combination of AK104 and Neoadjuvant Chemoradiotherapy in pMMR/MSS Locally Advanced Rectal Cancer Status RECRUITING Phase PHASE2
NCT05960955 Cadonilimab Combination With Chemotherapy With or Without AK117 in Resectable Gastric or Gastroesophageal Junction Adenocarcinoma Status RECRUITING Phase PHASE2
NCT05951608 A Phase Ib/II Clinical Study of AK127 in Combination With AK112 in Patients With Advanced Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05904379 AK112 and AK104 With or Without Chemotherapy in Advanced Non-small Cell Lung Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05868876 A Phase Ia/Ib Open Label,Clinical Study Evaluating the Safety, Tolerability and Preliminary Efficacy of AK127 in Combination With AK104 in Patients With Advanced Malignant Tumors Status RECRUITING Phase PHASE1